Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1277977
Max Phase: Preclinical
Molecular Formula: C16H12ClFN2S
Molecular Weight: 283.35
Molecule Type: Small molecule
Associated Items:
ID: ALA1277977
Max Phase: Preclinical
Molecular Formula: C16H12ClFN2S
Molecular Weight: 283.35
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[n+]1cc2c(c3ccccc31)Nc1ccc(F)cc1S2.[Cl-]
Standard InChI: InChI=1S/C16H11FN2S.ClH/c1-19-9-15-16(11-4-2-3-5-13(11)19)18-12-7-6-10(17)8-14(12)20-15;/h2-9H,1H3;1H
Standard InChI Key: CNOROWCLYTWMGV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 283.35 | Molecular Weight (Monoisotopic): 283.0700 | AlogP: 4.01 | #Rotatable Bonds: 0 |
Polar Surface Area: 15.91 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -0.37 | CX LogD: -0.37 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.49 | Np Likeness Score: -0.37 |
1. Zięba A, Sochanik A, Szurko A, Rams M, Mrozek A, Cmoch P.. (2010) Synthesis and in vitro antiproliferative activity of 5-alkyl-12(H)-quino[3,4-b] [1,4]benzothiazinium salts., 45 (11): [PMID:20813435] [10.1016/j.ejmech.2010.07.035] |
Source(1):